However, EGFR amplification was not predictive of survival in glioma treated with an inhibitor of EGFR concurrently with chemo and radiation therapy [8], and supporting evidence is limited for the role of EGFR-encoding DM in GBM recurrence following frontline radiotherapy. Here, EGFR is linked to glioblastoma.